Drug profile · INN
galantamine hydrobromide
GALANTAMINE HYDROBROMIDE
galantamine hydrobromide (GALANTAMINE HYDROBROMIDE) is a acetylcholinesterase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — galantamine hydrobromide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
galantamine hydrobromide (GALANTAMINE HYDROBROMIDE) is a acetylcholinesterase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Acetylcholinesterase inhibitor
Primary target: Acetylcholinesterase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is galantamine hydrobromide?
galantamine hydrobromide (GALANTAMINE HYDROBROMIDE) is a acetylcholinesterase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for galantamine hydrobromide?
GALANTAMINE HYDROBROMIDE is a marketed brand name for galantamine hydrobromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of galantamine hydrobromide?
galantamine hydrobromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.